| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K51490254 | CTRPv2 | pan-cancer | AAC | 0.031 | 0.4 |
| mRNA | BRD-K13999467 | CTRPv2 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | QS11 | GDSC1000 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | 0.03 | 0.4 |
| mRNA | cimetidine | CTRPv2 | pan-cancer | AAC | -0.054 | 0.4 |
| mRNA | Y-39983 | GDSC1000 | pan-cancer | AAC | -0.026 | 0.4 |
| mRNA | Pazopanib | GDSC1000 | pan-cancer | AAC | -0.028 | 0.4 |
| mRNA | ML258 | CTRPv2 | pan-cancer | AAC | 0.03 | 0.4 |
| mRNA | Bexarotene | GDSC1000 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | SN-38 | CTRPv2 | pan-cancer | AAC | 0.029 | 0.4 |